PL320610A1 - Fragments of monoclonal antibodies of immunosuppressive activity - Google Patents
Fragments of monoclonal antibodies of immunosuppressive activityInfo
- Publication number
- PL320610A1 PL320610A1 PL95320610A PL32061095A PL320610A1 PL 320610 A1 PL320610 A1 PL 320610A1 PL 95320610 A PL95320610 A PL 95320610A PL 32061095 A PL32061095 A PL 32061095A PL 320610 A1 PL320610 A1 PL 320610A1
- Authority
- PL
- Poland
- Prior art keywords
- fragments
- monoclonal antibodies
- immunosuppressive activity
- immunosuppressive
- activity
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
- C07K16/2833—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against MHC-molecules, e.g. HLA-molecules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US35091594A | 1994-12-07 | 1994-12-07 | |
PCT/EP1995/004648 WO1996017874A1 (en) | 1994-12-07 | 1995-11-25 | Monoclonal antibody fragments having immunosuppressant activity |
Publications (1)
Publication Number | Publication Date |
---|---|
PL320610A1 true PL320610A1 (en) | 1997-10-13 |
Family
ID=23378740
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL95320610A PL320610A1 (en) | 1994-12-07 | 1995-11-25 | Fragments of monoclonal antibodies of immunosuppressive activity |
Country Status (19)
Country | Link |
---|---|
EP (1) | EP0787151A1 (en) |
JP (1) | JP2001506122A (en) |
CN (1) | CN1168679A (en) |
AR (1) | AR002005A1 (en) |
AU (1) | AU4256096A (en) |
BR (1) | BR9509902A (en) |
CA (1) | CA2206471A1 (en) |
CO (1) | CO4480041A1 (en) |
CZ (1) | CZ172497A3 (en) |
FI (1) | FI972430A (en) |
HU (1) | HUT77342A (en) |
IL (1) | IL116228A0 (en) |
MA (1) | MA23739A1 (en) |
NO (1) | NO972522L (en) |
PE (1) | PE52996A1 (en) |
PL (1) | PL320610A1 (en) |
TR (1) | TR199501542A2 (en) |
WO (1) | WO1996017874A1 (en) |
ZA (1) | ZA9510195B (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0893507A1 (en) * | 1997-07-25 | 1999-01-27 | Institut Gustave Roussy | Use of MHC class II ligands (CD4 and LAG-3) as adjuvant for vaccination and of LAG-3 in cancer treatment |
WO2000012560A1 (en) | 1998-08-28 | 2000-03-09 | Dendreon Corporation | Selective apoptosis of neoplastic cells by an hla-dr specific monoclonal antibody |
EP1156060B1 (en) * | 2000-05-12 | 2007-06-27 | GPC Biotech AG | Human peptides/proteins causing or leading to the killing of cells including lymphoid tumor cells |
EP1156062A1 (en) * | 2000-05-12 | 2001-11-21 | GPC Biotech AG | Immunomodulatory human MHC class II antigen-binding peptides/proteins |
US7521047B2 (en) | 2000-05-12 | 2009-04-21 | Gpc Biotech Ag | Human polypeptides causing or leading to the killing of cells including lymphoid tumor cells |
AU2002340167A1 (en) | 2001-10-11 | 2003-06-17 | Protein Design Labs Inc. | Anti-hla-dr antibodies and the methods of using thereof |
KR20050036852A (en) | 2001-10-15 | 2005-04-20 | 기린 비루 가부시키가이샤 | Anti-hla-dr-antibody |
EP1768662A2 (en) | 2004-06-24 | 2007-04-04 | Novartis Vaccines and Diagnostics, Inc. | Small molecule immunopotentiators and assays for their detection |
CA2794499A1 (en) * | 2010-04-01 | 2011-10-06 | Immumomedics, Inc. | Antibody-based depletion of antigen-presenting cells and dendritic cells |
KR102647825B1 (en) * | 2021-07-22 | 2024-03-14 | 서울대학교산학협력단 | Anti-HLA-DP monoclonal antibody and use thereof |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3269354D1 (en) * | 1981-06-25 | 1986-04-03 | Univ Leland Stanford Junior | Allele specific immunotherapeutic method and dosage form |
WO1991010722A2 (en) * | 1989-12-27 | 1991-07-25 | Centocor, Inc. | Chimeric immunoglobulin for cd4 receptors |
DE69233011T2 (en) * | 1991-07-25 | 2003-11-06 | Idec Pharma Corp | RECOMBINANT ANTIBODIES FOR HUMAN THERAPY |
-
1995
- 1995-11-25 CA CA002206471A patent/CA2206471A1/en not_active Abandoned
- 1995-11-25 PL PL95320610A patent/PL320610A1/en unknown
- 1995-11-25 JP JP51728896A patent/JP2001506122A/en active Pending
- 1995-11-25 CN CN95196662A patent/CN1168679A/en active Pending
- 1995-11-25 WO PCT/EP1995/004648 patent/WO1996017874A1/en not_active Application Discontinuation
- 1995-11-25 BR BR9509902A patent/BR9509902A/en not_active Application Discontinuation
- 1995-11-25 EP EP95941017A patent/EP0787151A1/en not_active Withdrawn
- 1995-11-25 HU HU9702311A patent/HUT77342A/en unknown
- 1995-11-25 AU AU42560/96A patent/AU4256096A/en not_active Abandoned
- 1995-11-25 CZ CZ971724A patent/CZ172497A3/en unknown
- 1995-11-30 ZA ZA9510195A patent/ZA9510195B/en unknown
- 1995-12-01 IL IL11622895A patent/IL116228A0/en unknown
- 1995-12-04 PE PE1995286338A patent/PE52996A1/en not_active Application Discontinuation
- 1995-12-05 AR ARP950100448A patent/AR002005A1/en unknown
- 1995-12-05 CO CO95057748A patent/CO4480041A1/en unknown
- 1995-12-07 TR TR95/01542A patent/TR199501542A2/en unknown
- 1995-12-07 MA MA24090A patent/MA23739A1/en unknown
-
1997
- 1997-06-03 NO NO972522A patent/NO972522L/en unknown
- 1997-06-06 FI FI972430A patent/FI972430A/en unknown
Also Published As
Publication number | Publication date |
---|---|
CN1168679A (en) | 1997-12-24 |
TR199501542A2 (en) | 1996-07-21 |
MA23739A1 (en) | 1996-07-01 |
FI972430A0 (en) | 1997-06-06 |
AR002005A1 (en) | 1998-01-07 |
PE52996A1 (en) | 1996-12-12 |
NO972522D0 (en) | 1997-06-03 |
ZA9510195B (en) | 1996-06-07 |
HUT77342A (en) | 1998-03-30 |
CO4480041A1 (en) | 1997-07-09 |
BR9509902A (en) | 1997-10-21 |
NO972522L (en) | 1997-08-06 |
AU4256096A (en) | 1996-06-26 |
CA2206471A1 (en) | 1996-06-13 |
CZ172497A3 (en) | 1997-10-15 |
EP0787151A1 (en) | 1997-08-06 |
IL116228A0 (en) | 1996-03-31 |
FI972430A (en) | 1997-06-06 |
JP2001506122A (en) | 2001-05-15 |
WO1996017874A1 (en) | 1996-06-13 |
MX9704225A (en) | 1997-09-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL311926A1 (en) | Anti-alphav-integrinic monoclonal antibodies | |
IL128406A0 (en) | Monoclonal antibodies | |
EP0870826A4 (en) | Novel protein and monoclonal antibody specific thereto | |
IL136335A0 (en) | Monoclonal human natural antibodies | |
IL130143A0 (en) | Humanized anti-CD11a antibodies | |
EP0759071A4 (en) | Wt1 monoclonal antibodies and methods of use therefor | |
GB9422383D0 (en) | Antibodies | |
AU1289795A (en) | Monoclonal antibodies specific for human interleukin-5 | |
AU6702998A (en) | Anti-alphabeta3 humanized monoclonal antibodies | |
PL320610A1 (en) | Fragments of monoclonal antibodies of immunosuppressive activity | |
EP0977590A4 (en) | Human monoclonal antibodies | |
EP0909278A4 (en) | Nephropathy-related immunoglobulin g and antibodies for same | |
IL109232A0 (en) | Human monoclonal antibodies and processes and materials for making such antibodies | |
GB9718911D0 (en) | Monoclonal antibodies | |
ZA951113B (en) | Tumor assosiated monoclonal antibody 123av16 | |
AU2828795A (en) | Monoclonal antibodies for the reduction of anti-xenogeneic immune responses | |
GB9506425D0 (en) | New uses of monoclonal antibodies | |
GB9615027D0 (en) | Monoclonal antibodies | |
SI0742795T1 (en) | Immuno-stimulatory monoclonal antibodies | |
PL329866A1 (en) | Monoclonal antibody against human mp52 | |
EP0693121A4 (en) | Monoclonal antibody 88bv59, subclones and method of making | |
SG64332A1 (en) | Monoclonal antibody | |
GB9212074D0 (en) | Monoclonal antibody | |
GB9519460D0 (en) | Polyclonal antibodies and their use | |
GB9204514D0 (en) | Monoclonal antibodies and their use |